Revvity RVTY
NYSE RVTY
$157.25 +6.31 (+4.18%)
As of: Oct 20, 2026 · 2:14 PM EDT

Revvity (RVTY) Current Deferred Revenue (2014 - 2016)

Updated

Revvity (RVTY) recorded Current Deferred Revenue of $163.17 million in FY2016.

Analysis

Revvity (RVTY) Current Deferred Revenue (2014 - 2016) Analysis & Trends

  • Per Business Quant data, RVTY's Current Deferred Revenue was $168.93 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 256.00 Bn 235.03 Bn 4.88 Bn
2 Abbott Laboratories 178.69 Bn 149.12 Bn 7.27 Bn
3 Danaher 159.04 Bn 142.85 Bn 3.61 Bn
4 Intuitive Surgical 155.28 Bn 134.70 Bn 1.96 Bn
5 Medtronic 120.99 Bn 86.24 Bn 6.34 Bn
6 Stryker 116.81 Bn 102.93 Bn 4.50 Bn
7 Boston Scientific 66.96 Bn 61.73 Bn 3.85 Bn
8 Becton Dickinson 53.15 Bn 50.30 Bn 2.32 Bn
9 Edwards Lifesciences 50.74 Bn 34.75 Bn 1.35 Bn
10 Revvity 17.55 Bn 13.82 Bn 416.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jan 3, 2016 163.17 Mn
Dec 28, 2014 168.93 Mn
API Access

Revvity Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RVTY&period=max&api_key=YOUR_API_KEY